EGFR activating variants
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) | EGFR activating variants | Non-Small Cell Lung Cancer | Erlotinib, Ramucirumab | |
| EMA (1) | EGFR activating variants | Non-Small Cell Lung Cancer | Afatinib | |
| EMA (1) | EGFR activating variants | Non-Small Cell Lung Cancer | Osimertinib | |
| EMA (2) | EGFR activating variants | Non-Small Cell Lung Cancer | Erlotinib | |
| EMA (1) | EGFR activating variants | Non-Small Cell Lung Cancer | Dacomitinib |